Both in Biotechnology
Vir Biotechnology vs BioCryst Pharmaceuticals
Over the past year VIR returned +96.4% and BCRX returned +20.2%; their daily moves had a correlation of 0.24.
VIR +96.4% BCRX +20.2%Growth of $1, one year, split-adjusted
| Metric | VIR | BCRX |
|---|---|---|
| Price | $11.00 | $8.25 |
| Market cap | $1.86B | $2.11B |
| Today | −2.65% | −2.66% |
| 1 month | −1.5% | +0.9% |
| 6 months | +8.1% | −10.4% |
| Year to date | +82.4% | +5.7% |
| 1 year | +85.5% | +13.7% |
| Revenue growth (YoY) | +19582.5% | +33.6% |
| Gross margin | 100.0% | 98.2% |
| Net margin | 33.5% | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | 2.2× |
| Net cash | $532.7M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 45.3% |
| Short % of float | 12.3% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).